TY - JOUR
T1 - N-Acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration
AU - Winefield, Robert D.
AU - Heemskerk, Anthonius A.M.
AU - Kaul, Swetha
AU - Williams, Todd D.
AU - Caspers, Michael J.
AU - Prisinzano, Thomas E.
AU - McCance-Katz, Elinore F.
AU - Lunte, Craig E.
AU - Faiman, Morris D.
N1 - Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/3/5
Y1 - 2015/3/5
N2 - Disulfiram (DSF), a treatment for alcohol use disorders, has shown some clinical effectiveness in treating addiction to cocaine, nicotine, and pathological gambling. The mechanism of action of DSF for treating these addictions is unclear but it is unlikely to involve the inhibition of liver aldehyde dehydrogenase (ALDH2). DSF is a pro-drug and forms a number of metabolites, one of which is N-acetyl-. S-(N,N-diethylcarbamoyl) cysteine (DETC-NAC). Here we describe a LCMS/MS method on a QQQ type instrument to quantify DETC-NAC in plasma and intracellular fluid from mammalian brain. An internal standard, the N,N-di-isopropylcarbamoyl homolog (MIM: 291. >. 128) is easily separable from DETC-NAC (MIM: 263. >. 100) on C18 RP media with a methanol gradient. The method's linear range is 0.5-500. nM from plasma and dialysate salt solution with all precisions better than 10% RSD. DETC-NAC and internal standards were recovered at better than 95% from all matrices, perchloric acid precipitation (plasma) or formic acid addition (salt) and is stable in plasma or salt at low pH for up to 24. h. Stability is observed through three freeze-thaw cycles per day for 7 days. No HPLC peak area matrix effect was greater than 10%. A human plasma sample from a prior analysis for S-(N,N-diethylcarbamoyl) glutathione (CARB) was found to have DETC NAC as well. In other human plasma samples from 62.5. mg/d and 250. mg/d dosing, CARB concentration peaks at 0.3 and 4. nM at 3. h followed by DETC-NAC peaks of 11 and 70. nM 2. h later. Employing microdialysis sampling, DETC-NAC levels in the nucleus accumbens (NAc), medial prefrontal cortex (mPFC), and plasma of rats treated with DSF reached 1.1, 2.5 and 80. nM at 6. h. The correlation between the appearance and long duration of DETC-NAC concentration in rat brain and the persistence of DSF-induced changes in neurotransmitters observed by Faiman et al. (Neuropharmacology, 2013, 75C, 95-105) is discussed.
AB - Disulfiram (DSF), a treatment for alcohol use disorders, has shown some clinical effectiveness in treating addiction to cocaine, nicotine, and pathological gambling. The mechanism of action of DSF for treating these addictions is unclear but it is unlikely to involve the inhibition of liver aldehyde dehydrogenase (ALDH2). DSF is a pro-drug and forms a number of metabolites, one of which is N-acetyl-. S-(N,N-diethylcarbamoyl) cysteine (DETC-NAC). Here we describe a LCMS/MS method on a QQQ type instrument to quantify DETC-NAC in plasma and intracellular fluid from mammalian brain. An internal standard, the N,N-di-isopropylcarbamoyl homolog (MIM: 291. >. 128) is easily separable from DETC-NAC (MIM: 263. >. 100) on C18 RP media with a methanol gradient. The method's linear range is 0.5-500. nM from plasma and dialysate salt solution with all precisions better than 10% RSD. DETC-NAC and internal standards were recovered at better than 95% from all matrices, perchloric acid precipitation (plasma) or formic acid addition (salt) and is stable in plasma or salt at low pH for up to 24. h. Stability is observed through three freeze-thaw cycles per day for 7 days. No HPLC peak area matrix effect was greater than 10%. A human plasma sample from a prior analysis for S-(N,N-diethylcarbamoyl) glutathione (CARB) was found to have DETC NAC as well. In other human plasma samples from 62.5. mg/d and 250. mg/d dosing, CARB concentration peaks at 0.3 and 4. nM at 3. h followed by DETC-NAC peaks of 11 and 70. nM 2. h later. Employing microdialysis sampling, DETC-NAC levels in the nucleus accumbens (NAc), medial prefrontal cortex (mPFC), and plasma of rats treated with DSF reached 1.1, 2.5 and 80. nM at 6. h. The correlation between the appearance and long duration of DETC-NAC concentration in rat brain and the persistence of DSF-induced changes in neurotransmitters observed by Faiman et al. (Neuropharmacology, 2013, 75C, 95-105) is discussed.
KW - Carbamathione
KW - DETC-NAC
KW - Disulfiram
KW - Mercapturate pathway
KW - Substance abuse disorders
UR - http://www.scopus.com/inward/record.url?scp=84923164543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923164543&partnerID=8YFLogxK
U2 - 10.1016/j.jpba.2015.01.036
DO - 10.1016/j.jpba.2015.01.036
M3 - Article
C2 - 25720821
AN - SCOPUS:84923164543
SN - 0731-7085
VL - 107
SP - 518
EP - 525
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
ER -
